Passage Bio

1 follower

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).






Org chart

William Chou
President & CEO

William Chou

Mark Forman
Chief Medical Officer
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
Desiree Luthman
SVP, Global Regulatory Affairs
Jiwen Zhang
VP, Regulatory Affairs
Samiah Al-Zaidy
VP, Clinical Development
Kathleen Borthwick
VP, Financial Planning & Analysis
Eden Fucci
VP, Manufacturing Operations
Zied Mjaied
VP, Supply Chain & Planning
Tiffini Voss
VP, Clinical Development
Stuart Henderson
VP, Corporate Development & Investor Relations
Andrea Campanile
VP, Clinical Operations
Sue Browne
VP, Biology